glp 1 and kidney Design discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis GLP-1s are back in the

Riis KR, Larsen CB, Medici BR, Jensen CZ, Winther KH, Larsen EL, Ellervik C, Cour JL la, Hegeds L, Brix TH, Poulsen HE, Knop FK, Nygaard B, Bonnema SJ

Understanding these fundamental effects on digestion helps contextualize why some patients and practitioners consider supplemental digestive enzymes during treatment, though the evidence base for this practice requires careful examination

152 Potential mechanisms for this action are suppression of cholesterol synthesis by inhibition of the HMG-CoA reductase enzyme or an increase in the rate of LDL degradation

7 Urinary excretion of unchanged carnitine is the major route of elimination of carnitine